[HIV/AIDS infection in Area 11 of Madrid: a panorama from the primary care viewpoint]
Aten Primaria. 1997 Sep 30;20(5):243-6. Unique Identifier : AIDSLINE MED/98030143 Roset Monros P; Rodriguez Fernandez C; Lobon Agundez C; Martin Alvarez R; Hernando Lopez T; Velazquez Garcia A; Unidad Docente de Medicina Familiar y Comunitaria, Area XI, Madrid.
Abstract:
OBJECTIVES: To find the clinical and epidemiological characteristics of HIV-positive patients and to study the possible differences between patients attended by primary care teams (PCT) and by the hospital specialist unit (SU). DESIGN: A descriptive cross-sectional study. SETTING: Six PCTs in Villaverde, Usera and Carabanchel (Madrid). PATIENTS: Those infected with HIV and in the morbidity records between January 1992 and January 1995. MEASUREMENTS AND MAIN RESULTS: 274 cases were studied. The most important risk practice was being IDU intravenous drugs user) (80.3%). The most definitive and linked AIDS-related illness was Tuberculosis (39.7%). Patients treated with Zidovudine (or AZT) were monitored by PCTs (p = 0.004), as were those not needing day-hospital treatment (p = 0.0005). CONCLUSIONS: HIV infection in our environment follows the typical clinical and epidemiological pattern of this country: transmitted by IDUs, with its most frequent associated infection being tuberculosis. With the exception of AZT or day-hospital treatment, its clinical and epidemiological features are similar in PCTs and SUs. Information and responsible participation of PCT professionals in caring for HIV-positive patients are the key strategies for guaranteeing the quality of health care delivery.
Keywords: *Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY *HIV Infections/EPIDEMIOLOGY *HIV-1 *Primary Health Care/STATISTICS & NUMER DATA *Urban Population/STATISTICS & NUMER DATA 980430
M9841837
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
